Evidence map›Paper›PMID 33652938›Full record

ArticleMolecules (Basel, Switzerland)2021

Clinical Relevance of [

Damiano Librizzi, Nicole Cabanel, Maxim Zavorotnyy, Elisabeth Riehl, Tilo Kircher, Markus Luster, Behrooz Hooshyar Yousefi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Damiano LibrizziDepartment of Nuclear Medicine, Philipps-University of Marburg, 35043 Marburg, Germany.
Nicole CabanelDepartment of Psychiatry and Psychotherapy, Philipps-University of Marburg, 35039 Marburg, Germany.
Maxim ZavorotnyyDepartment of Psychiatry and Psychotherapy, Philipps-University of Marburg, 35039 Marburg, Germany.
Elisabeth RiehlDepartment of Nuclear Medicine, Philipps-University of Marburg, 35043 Marburg, Germany.
Tilo KircherDepartment of Psychiatry and Psychotherapy, Philipps-University of Marburg, 35039 Marburg, Germany.
Markus LusterDepartment of Nuclear Medicine, Philipps-University of Marburg, 35043 Marburg, Germany.
Behrooz Hooshyar YousefiDepartment of Nuclear Medicine, Philipps-University of Marburg, 35043 Marburg, Germany.ORCID 0000-0003-0679-4449
Philipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PET of β-Amyloid plaques (Aβ) using

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesBrainCognitive DysfunctionDementiaFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedPositron Emission Tomography Computed Tomographytau ProteinsAmyloid beta-PeptidesFluorodeoxyglucose F18tau ProteinsAlzheimer’s diseasedementiadiagnostic imagingMCIneurofibrillary tanglespatient managementPositron Emission Tomography (PET)β-amyloid plaques

Identifiers

PMID33652938
PMCPMC7956266
OpenAlexW3135324535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.